Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main purpose of the CHIPS trial is to evaluate the efficacy and safety of colchicine in heart failure with preserved ejection fraction (HFpEF) patients with inflammation, including the effects of colchicine on circulating inflammatory markers, cardiac structure, cardiac function, clinical symptoms and exercise capacity in HFpEF patients.
Epistemonikos ID: ef0674f350334a6e7348f301cdf7c6a3fa67f054
First added on: Oct 01, 2024